ADA Scientific Sessions 2026 Abstract

Improved Treatment Satisfaction with Once-Weekly IcoSema vs. Once-Daily Glargine U100 in Insulin-Naive Adults with Type 2 Diabetes (COMBINE 4)

By Liming Chen, Malik Benamar, Benjamin Hilligsøe Harvey, Paolo Fiorina

Trial in peopleInterventions

The paper

Liming Chen, Malik Benamar, Benjamin Hilligsøe Harvey, Paolo Fiorina

Tianjin

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1752-P

doi.org/10.2337/db26-1752-p

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial